INVST’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-2,514
Closed -$222K 169
2022
Q4
$222K Sell
2,514
-1,497
-37% -$144K 0.03% 155
2022
Q3
$354K Buy
4,011
+70
+2% +$6.93K 0.06% 132
2022
Q2
$410K Sell
3,941
-281
-7% -$27.4K 0.06% 134
2022
Q1
$417K Buy
4,222
+26
+0.6% +$2.73K 0.07% 134
2021
Q4
$429K Sell
4,196
-4,537
-52% -$419K 0.07% 131
2021
Q3
$741K Buy
8,733
+251
+3% +$21K 0.12% 89
2021
Q2
$693K Buy
8,482
+582
+7% +$47.7K 0.11% 91
2021
Q1
$604K Buy
7,900
+1,150
+17% +$83.8K 0.1% 98
2020
Q4
$461K Buy
6,750
+568
+9% +$36.9K 0.08% 115
2020
Q3
$358K Buy
6,182
+681
+12% +$42.4K 0.08% 103
2020
Q2
$355K Buy
+5,501
New +$346K 0.11% 87

Other funds holding CVS

INVST's CVS Position: Q1 2023 in Review

INVST sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,514 shares — an estimated $222K sold.

INVST first reported a position in CVS in Q2 2020 and held it in 11 quarters. The position peaked at $741K in Q3 2021. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

  • INVST reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
  • INVST sold 2,514 CVS Health shares in Q1 2023, an estimated $222K.
  • INVST first reported a position in CVS Health in Q2 2020 and held it in 11 quarters.
  • INVST's CVS Health position peaked at $741K in Q3 2021.
  • 2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on INVST's 13F filing for Q1 2023, filed 28 Apr 2023.